Israeli medical company Dune Medical Devices inc., has received FDA approval for its MarginProbe device, which improves results of tumor removal in breast cancer patients. Dune Medical, which was founded in 2004, has raised $30 to date and says it will continue developing other devices for the medical market.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts
Israeli AI Safety Tool Among TIME’S Best Inventions For 2024
October 31, 2024
TAU Team Discovers Mechanism To Eliminate Cancerous Tumors
October 30, 2024
Ashdod Port Investing In Startups As Part Of Innovation Strategy
October 29, 2024
BGU Develops Fast Fact Checking Via News Sources Not People
October 28, 2024
Facebook comments